Hematological Malignancies

Ensure that the unique biology of lymphoid malignancies is exploited in RT planning and delivery In general no survival advantage has been demonstrated with the extended fields of the past

The unique radiosensitivity of lymphoid malignancies means that dose constraints for normal tissues used for solid tumours are not applicable

Modern conformal techniques should be used for lymphomas, not primarily as in solid tumours to allow a high target dose to be delivered, but to minimize the risk of long-term complications

Different techniques are applicable to different disease localizations and disease volumes, no two patients are the same